View in EDS HTML Full Text PDF Full Text

Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis.

Saved in:
Bibliographic Details
Title: Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis.
Authors: Elborn JS; Centre for Infection and Immunity, Dentistry, and Biomedical Sciences, Queens University School of Medicine, Belfast, UK., Horsley A; Centre for Respiratory Medicine and Allergy, Institute of Inflammation and Repair, University of Manchester, Manchester, UK., MacGregor G; West of Scotland CF Centre, Gartnavel General Hospital, Glasgow, UK., Bilton D; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK., Grosswald R; Celtaxsys, Inc, Atlanta, Georgia, USA., Ahuja S; Celtaxsys, Inc, Atlanta, Georgia, USA., Springman EB; Celtaxsys, Inc, Atlanta, Georgia, USA.
Source: Clinical and translational science [Clin Transl Sci] 2017 Jan; Vol. 10 (1), pp. 28-34. Date of Electronic Publication: 2016 Nov 02.
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial
Journal Info: Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 27806191
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Elborn+JS%22">Elborn JS</searchLink>; Centre for Infection and Immunity, Dentistry, and Biomedical Sciences, Queens University School of Medicine, Belfast, UK.<br /><searchLink fieldCode="AU" term="%22Horsley+A%22">Horsley A</searchLink>; Centre for Respiratory Medicine and Allergy, Institute of Inflammation and Repair, University of Manchester, Manchester, UK.<br /><searchLink fieldCode="AU" term="%22MacGregor+G%22">MacGregor G</searchLink>; West of Scotland CF Centre, Gartnavel General Hospital, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Bilton+D%22">Bilton D</searchLink>; Department of Respiratory Medicine, Royal Brompton Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Grosswald+R%22">Grosswald R</searchLink>; Celtaxsys, Inc, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Ahuja+S%22">Ahuja S</searchLink>; Celtaxsys, Inc, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Springman+EB%22">Springman EB</searchLink>; Celtaxsys, Inc, Atlanta, Georgia, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101474067%22">Clinical and translational science</searchLink> [Clin Transl Sci] 2017 Jan; Vol. 10 (1), pp. 28-34. <i>Date of Electronic Publication: </i>2016 Nov 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22WileyBlackwell+Pub%22">WileyBlackwell Pub </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101474067 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1752-8062 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217528054%22">17528054 </searchLink><i>NLM ISO Abbreviation: </i>Clin Transl Sci <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27806191
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/cts.12428
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 28
    Titles:
      – TitleFull: Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Elborn JS
      – PersonEntity:
          Name:
            NameFull: Horsley A
      – PersonEntity:
          Name:
            NameFull: MacGregor G
      – PersonEntity:
          Name:
            NameFull: Bilton D
      – PersonEntity:
          Name:
            NameFull: Grosswald R
      – PersonEntity:
          Name:
            NameFull: Ahuja S
      – PersonEntity:
          Name:
            NameFull: Springman EB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2017 Jan
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1752-8062
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Clinical and translational science
              Type: main
ResultId 1